Nkarta Inc.

Nkarta Inc.

World Rank (Jan-05-2024)
15,865
Market Cap (Jan-05-2024)
0.295 Billion USD
World Rank (Jul-30-2023)
21,405
Market Cap (Jul-30-2023)
0.105 Billion USD
World Rank (Jan-07-2022)
14,069
Market Cap (Jan-07-2022)
0.445 Billion USD
World Rank (Jan-01-2021)
5,453
Market Cap (Jan-01-2021)
2.004 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
NKTX
Market Cap (Mar-08-2026)
0.18
Employee Count
87
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-91 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Balance Sheet for Period Ending
Dec-2020 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
NKARTA, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile
Nkarta is a Clinical Stage Biotechnology company improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. The company annual revenue is less 1 million USD and 70 employees as on 2019. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share